NDC 18657-117 – HYLENEX Recombinant
Hyaluronidase (human Recombinant) 150 [USP'U]/mL · Injection, Solution · Subcutaneous
Product NDC18657-117
Product details
- Brand name
- HYLENEX Recombinant
- Generic name
- Hyaluronidase
- Labeler
- Antares Pharma, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA021859
- Marketed since
- December 2, 2005
- Listing expires
- December 31, 2026
- Pharmacologic class
- Endoglycosidase
Active ingredients
- Hyaluronidase (human Recombinant) 150 [USP'U]/mL
Uses, dosage, side effects and warnings for HYLENEX Recombinant →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 18657-117-04 | 4 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01) | Dec 2, 2005 |
Recalls mentioning this NDC
- D-0116-2025 Dec 18, 2024 · Class II
cGMP Deviations: Temperature excursion